TCL Archive Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer February 29, 2008
TCL Archive LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter. October 17, 2008